← Every company
Amylyx Pharmaceuticals Inc SEC Filings
What Amylyx Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
AMLX overview →Filings on file
59
since Dec 16, 2021
Warning signs
0
none filed
Last results
Aug 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
Source: Amylyx Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on AMLX
Company overviewEverything on AMLX in one place, with the price.Insider tradingWhat AMLX's own officers and directors buy and sell.Planned salesSales AMLX insiders have filed notice of.Who owns itEvery manager reporting a position in AMLX.Funds holding itWhich funds and ETFs hold AMLX, and how big a bet.LobbyingWhat AMLX spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on AMLX's account, and who they worked for.PatentsWhat AMLX is filing at the patent office.